NSIM
BIVI icon

North Star Investment Management’s BioVie BIVI Stock Holding History

North Star Investment Management’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$8.08K – 1297
2023
Q1 		$8.08K Hold
10
– – ﹤0.01% 902
2022
Q4 		$7.77K Buy
+10
New +$5.41K ﹤0.01% 891

Other funds holding BIVI

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

North Star Investment Management's BIVI Position: Q2 2023 in Review

North Star Investment Management sold out of BioVie (BIVI) in Q2 2023, closing a stake of 10 shares — an estimated $8.08K sold.

North Star Investment Management first reported a position in BIVI in Q4 2022 and held it in 2 quarters. The position peaked at $8.08K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q2 2023.

  • North Star Investment Management reported no remaining BioVie position as of Q2 2023 after selling out during the quarter.
  • North Star Investment Management sold 10 BioVie shares in Q2 2023, an estimated $8.08K.
  • North Star Investment Management first reported a position in BioVie in Q4 2022 and held it in 2 quarters.
  • North Star Investment Management's BioVie position peaked at $8.08K in Q1 2023.
  • 53 funds tracked by Wall St. Rank held BioVie as of Q2 2023.

Based on North Star Investment Management's 13F filing for Q2 2023, filed 2 Aug 2023.